8-Fluoro-2-(4-methylpiperazin-1-yl)indolo[2,1-b]quinazoline-6,12-dione

ID: ALA4536439

Chembl Id: CHEMBL4536439

PubChem CID: 85469240

Max Phase: Preclinical

Molecular Formula: C20H17FN4O2

Molecular Weight: 364.38

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc3nc4n(c(=O)c3c2)-c2ccc(F)cc2C4=O)CC1

Standard InChI:  InChI=1S/C20H17FN4O2/c1-23-6-8-24(9-7-23)13-3-4-16-14(11-13)20(27)25-17-5-2-12(21)10-15(17)18(26)19(25)22-16/h2-5,10-11H,6-9H2,1H3

Standard InChI Key:  OSSUXLNEXORTJB-UHFFFAOYSA-N

Associated Targets(Human)

IDO1 Tchem Indoleamine 2,3-dioxygenase (6650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IDO2 Tchem Indoleamine 2,3-dioxygenase 2 (287 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDO2 Tchem Tryptophan 2,3-dioxygenase (1554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.38Molecular Weight (Monoisotopic): 364.1336AlogP: 1.82#Rotatable Bonds: 1
Polar Surface Area: 58.44Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.59CX LogP: 2.49CX LogD: 2.09
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -0.84

References

1. Yang D, Zhang S, Fang X, Guo L, Hu N, Guo Z, Li X, Yang S, He JC, Kuang C, Yang Q..  (2019)  N-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase.,  62  (20): [PMID:31580660] [10.1021/acs.jmedchem.9b01079]
2. He G, Wan S, Wu Y, Chu Z, Shen H, Zhang S, Chen L, Bao Z, Gu S, Huang J, Huang L, Gong G, Zou Y, Zhu Q, Xu Y..  (2022)  Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.,  65  (21.0): [PMID:35952367] [10.1021/acs.jmedchem.2c00263]

Source